---
title: 4basebio vs Maravai LifeSciences
slug_a: 4basebio
slug_b: maravai
site: cdmo
review_signal_gate: closed
canonical_path: /compare/4basebio/maravai
---

# 4basebio vs Maravai LifeSciences

Side-by-side profile data from each company listing on this directory.

## 4basebio

- Profile: [/companies/4basebio](/companies/4basebio)

4basebio — 4basebio manufactures high-quality synthetic DNA and RNA using proprietary cell-free amplification technology, supporting mRNA vaccines, viral vectors, gene editing, and cell/gene therapies from research through GMP-grade clinical production.

Services: 7. Modalities: 3. Indications: 0. Locations: 3. Certifications: 1. The strongest documented coverage currently appears in services (7).

### Services

- Cell-Line Development
- Viral Vector Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Process Development
- Formulation Development
- CMC Analytical Development

### Modalities

- mRNA
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Expression: Cell-Free

## Maravai LifeSciences

- Profile: [/companies/maravai](/companies/maravai)

Maravai LifeSciences — Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.

Services: 11. Modalities: 6. Indications: 5. Locations: 0. Certifications: 2. The strongest documented coverage currently appears in services (11).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- mRNA Manufacturing
- Oligonucleotide Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- mRNA
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Cell-Free